10-04-2024
|
|
|
SMS Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 |
|
|
|
02-04-2024
|
|
|
SMS Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
|
|
|
02-04-2024
|
|
|
SMS PHARMACEUTICALS LIMITED has informed the Exchange about Closure of Trading Window |
|
|
|
20-03-2024
|
|
|
SMS Pharmaceuticals Limited has informed the Exchange regarding allotment of 9000000 securities pursuant to Preferential Issue at its meeting held on March 19, 2024 |
|
|
|
20-03-2024
|
|
|
SMS PHARMACEUTICALS LIMITED has informed the Exchange regarding Allotment of Securities |
|
|
|
19-03-2024
|
|
|
SMS Pharmaceuticals Limited has informed the Exchange regarding allotment of 9000000 securities pursuant to Preferential Issue at its meeting held on March 19, 2024 |
|
|
|
19-03-2024
|
|
|
SMS PHARMACEUTICALS LIMITED has informed the Exchange regarding Allotment of Securities |
|
|
|
07-03-2024
|
|
|
SMS Pharmaceuticals Limited has informed the Exchange regarding Proceedings of Extraordinary General Meeting held on March 06, 2024 |
|
|
|
07-03-2024
|
|
|
SMS Pharmaceuticals Limited has submitted the Exchange a copy Srutinizers report of Extraordinary General Meeting held on March 06, 2024. Further, the company has informed the Exchange regarding voting results. |
|
|
|
06-03-2024
|
|
|
SMS Pharmaceuticals Limited has informed the Exchange regarding Proceedings of Extraordinary General Meeting held on March 06, 2024 |
|
|
|
|
|